Journal profile · PHARMACOLOGY & PHARMACY-TOXICOLOGY

BMC Pharmacology & Toxicology

ISSN 1471-2210 · BioMed Central · ENGLAND · Founded 2001

Journal homepage ↗Submission system ↗Author guidelines ↗

BMC Pharmacology & Toxicology: CAS Zone 3 · Medicine (2025 upgraded edition); impact factor 3.51; fully open access; APC about USD 2,890; review about 12 weeks (community reports); 239 articles a year; indexed in SCIE and Scopus; the journal's website says submissions are paused or closed.

The journal's website says submissions are paused or closed: BMC Pharmacology is now archived and no longer receiving submissions with this publisher. All articles published in the journal during its time with Springer will remain fully searchable through our websites. Source ↗Publisher website · 2026-09-29

Impact factor3.51Latest value listed by LetPub

CAS zoneZone 3 · Medicine2025 upgraded edition, major category · 2026 Xinrui edition Zone 3 · Medicine

Review timeabout 12 weeksCommunity average

APCUSD 2,890Fully open access

Acceptance—No reports yet

Articles per year239LetPub annual count

Scope

Aims, scope and focus

BMC Pharmacology & Toxicology is published by BioMed Central and is in Zone 3 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Nitric Oxide and Endothelin Effects, Receptor Mechanisms and Signaling and Phosphodiesterase function and regulation, together about 38.5% of its articles. Its main subfields are Molecular Biology. (generated from OpenAlex topic counts and CAS ranking data)

BMC Pharmacology is an open access journal publishing original peer-reviewed research articles in aspects of the discovery, design, uses, effects, modes of ...

From the journal's Aims & Scope

Research area (LetPub): PHARMACOLOGY & PHARMACY-TOXICOLOGY

Main research topics OpenAlex counts of recent articles; shares are approximate

Nitric Oxide and Endothelin EffectsMedicine20.3%
Receptor Mechanisms and SignalingBiochemistry, Genetics and Molecular Biology11.1%
Phosphodiesterase function and regulationBiochemistry, Genetics and Molecular Biology7.1%
Neuroscience and Neuropharmacology ResearchNeuroscience4.8%
Neuropeptides and Animal PhysiologyNeuroscience4.7%
Heart Failure Treatment and ManagementMedicine4.6%
Ion channel regulation and functionBiochemistry, Genetics and Molecular Biology4.2%
Renin-Angiotensin System StudiesMedicine4.1%

Rankings & indexing

CAS ranking and database indexing

CAS Journal Ranking

CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 3

Level	Category	Zone
Major	Medicine	Zone 3
Minor	Toxicology	Zone 2
Minor	Pharmacology & Pharmacy	Zone 3

Top journal: noReview journal: no

CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3

Level	Category	Zone
Major	Medicine	Zone 3
Minor	Pharmacology & Pharmacy	Zone 3
Minor	Toxicology	Zone 2

Top journal: noReview journal: not marked

CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 3

Level	Category	Zone
Major	Medicine	Zone 3
Minor	Pharmacology & Pharmacy	Zone 3
Minor	Toxicology	Zone 3

Top journal: noReview journal: no

Database indexing

SCIEScopusLetPub

International journal early-warning lists: not listed in any editionLetPub

Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.

Metrics

Impact metrics and publication volume

Impact

Impact factor: 3.51LetPub · 2026-09-13
CiteScore 2026-06: 4.1LetPub · 2026-09-13
SJR 2026-06: 0.75LetPub · 2026-09-13
SNIP 2026-06: 0.97LetPub · 2026-09-13
h-index: 19LetPub · 2026-09-13
h-index: 55OpenAlex · 2026-10-01
i10-index: 194OpenAlex · 2026-10-01
2-year mean citedness: 0OpenAlex · 2026-10-01
Self-citation rate: 0%LetPub · 2026-09-13
Share of gold OA articles: 98.79%LetPub · 2026-09-13

Volume

Articles per year: 239LetPub · 2026-09-13

Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.

Review & acceptance

Review time and acceptance

Average review time (community reports): about 12 weeksLetPub · 2026-09-13

Peer review: Open peer reviewLetPub

Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.

Fees & open access

APC and open-access policy

Fully open accessLetPub

Every article is open access; authors usually pay an article processing charge (APC).

Source	APC	Fee waiver	License	Observed
LetPub	GBP 2,090 / USD 2,890 / EUR 2,390	Yes	—	2026-09-13

The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.

Profile

Publication details and official links

Publisher: BioMed Central
Country or region: ENGLAND
Language: English
Founded: 2001
ISSN: 1471-2210
Official links: Journal homepage ↗OpenAlex
Submission system ↗LetPub
Author guidelines ↗LetPub
Aims & Scope ↗LetPub
Peer review process ↗LetPub
Editorial board ↗LetPub

FAQ

Frequently asked questions about BMC Pharmacology & Toxicology

What CAS zone is BMC Pharmacology & Toxicology in?

In the 2025 upgraded edition of the CAS Journal Ranking, BMC Pharmacology & Toxicology is in Zone 3 of Medicine, and in Zone 2 of the minor category Toxicology / Pharmacology & Pharmacy. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.

What is the impact factor of BMC Pharmacology & Toxicology?

The latest impact factor listed by LetPub is 3.51; CiteScore 4.1, h-index 55.

How long does peer review take at BMC Pharmacology & Toxicology?

Authors report an average review time of about 12 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.

Which databases index BMC Pharmacology & Toxicology?

According to LetPub and DOAJ records, BMC Pharmacology & Toxicology is indexed in SCIE and Scopus.

Is BMC Pharmacology & Toxicology open access, and what is the APC?

BMC Pharmacology & Toxicology is a fully open-access journal. APC about USD 2,890.

Sources and updates

The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: 2026-10-01.